Remove Resources APIs-active-pharmaceutical-ingredients
article thumbnail

Monitoring pharmaceuticals in the environment

European Pharmaceutical Review

What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). Another important consideration is the sampling point.

article thumbnail

Novel cancer therapeutic synthesised by Stanford researchers

European Pharmaceutical Review

Small doses of EBC-46 injected into solid tumours modified the cellular signalling, activating certain forms of PKC. This process influences protein activity in cancerous cells, causing tumours to become inflamed and the blood vessels to haemorrhage and die.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How global healthcare partners and Indian pharma companies are contributing to affordable medicines

Express Pharma

As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most. Such partnerships are particularly valuable in addressing the healthcare needs of low- and middle-income countries.

Vaccines 103
article thumbnail

Dr Mansukh Mandaviya inaugurates 27 greenfield bulk drug park projects and 13 medical devices plants under the PLI Scheme

Express Pharma

During the COVID-19 pandemic, the dangers of supply chain getting affected, the risks of being highly dependent on imports of critical resources like bulk drugs and medical devices and its potential effects on India’s pharma and MedTech sector led to a lot of brainstorming within the Union Government. Dr. Arunish Chawla, Secretary; Dept.

article thumbnail

There has been a strong wave of M&A activity in Indian domestic formulations space

Express Pharma

During 2021 and 2022, the firm successfully advised on over 1,000 M&A deals globally, which makes us the most active global advisor by volume of transactions. It is also a globally interconnected sector, especially in pharma and medical devices, which leads to a large volume of cross-border activity for us. With a global team of c.100

article thumbnail

Reflecting on five years of quality control for nitrosamine impurities

European Pharmaceutical Review

This challenge is further compounded by increasingly complex drug formulations and global ingredient supply chains that stretch manufacturers’ capabilities in testing and control of impurities. First detection of nitrosamine impurities in pharmaceuticals The first reports of nitrosamines as a known animal carcinogens date back to 1956.

article thumbnail

How can the pharma industry navigate issues in the global supply chain to minimise drug shortages?

pharmaphorum

The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. Businesses are facing challenges in obtaining raw ingredients for medicines. Logistical challenges. Building supply chain resilience.

Diabetes 111